- Home
- SYRE vs PGNY Comparison
SYRE vs PGNY Comparison
Compare SYRE & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | PGNY |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SYRE | PGNY |
|---|---|---|
| Price | $34.13 | $25.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $56.50 | $27.90 |
| AVG Volume (30 Days) | 620.6K | ★ 1.4M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.96 |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | ★ $1,268,689,000.00 |
| Revenue This Year | N/A | $11.63 |
| Revenue Next Year | N/A | $9.52 |
| P/E Ratio | ★ N/A | $41.23 |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $10.91 | $17.98 |
| 52 Week High | $35.31 | $28.75 |
Technical Indicators
Market Signals| Indicator | SYRE | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 46.16 |
| Support Level | $31.62 | $24.10 |
| Resistance Level | $34.21 | $25.78 |
| Average True Range (ATR) | 1.91 | 1.20 |
| MACD | 0.13 | -0.25 |
| Stochastic Oscillator | 85.92 | 19.35 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.